Perinatal stem cells revisited: Directions and indications at the crossroads between tissue regeneration and repair

Current Stem Cell Research and Therapy

Volumn 8, Issue 1, 2013, Pages 2-5

  La Rocca, Giampiero ^a,b   Anzalone, Rita ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto Euro Mediterraneo di Scienza e Tecnologia IEMEST   (Italy)

Author keywords

Amniotic epithelium; Amniotic fluid; Amniotic membrane; Immune modulation; Mesenchymal stem cells; Perinatal stem cells; Placenta; Regenerative medicine; Tissue repair; Umbilical cord; Umbilical cord blood; Wharton's jelly

Indexed keywords

AMNION; AMNION CELL; AMNION FLUID; EDITORIAL; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PERINATAL STEM CELL; PLACENTA; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE REPAIR; UMBILICAL CORD; UMBILICAL CORD BLOOD;

HUMANS; INFANT, NEWBORN; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING; WOUND HEALING;

EID: 84879764477     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308010002     Document Type: Editorial

References (26)

1. La Rocca G, Corrao S, Lo Iacono M, Corsello T, Farina F, Anzalone R. Novel immunomodulatory markers expressed by WJMSC: an updated review in regenerative and reparative medicine. Open Tissue Eng Regen Med J 2012; 5: 50-8.
2. Silini A, Parolini O, Huppertz B, Lang I. Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies. Curr Stem Cell Res Ther 2013; 8(1): 6-14.
3. La Rocca G. Connecting the dots: the promises of Wharton's jelly mesenchymal stem cells for tissue repair and regeneration. Open Tissue Eng Regen Med J 2011; 4: 3-5.
4. Anzalone R, Lo Iacono M, Corrao S, et al. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cell Dev 2010; 19: 423-38.
5. Vaghjiani V, Vaithilingam V, Tuch B, Sievert W, Manuelpillai U. Deriving hepatocyte-like cells from placental cells for transplantation. Curr Stem Cell Res Ther 2013; 8(1): 15-24.
6. Sanberg PR, Eve DJ, Metcalf C, Borlongan CV. Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke. Prog Brain Res 2012; 201: 99-117.
7. Borlongan CV. Recent preclinical evidence advancing cell therapy for Alzheimer's disease. Exp Neurol 2012; 237: 142-6.
8. Vawda R, Fehlings MG. Mesenchymal Cells in the Treatment of Spinal Cord Injury: Current & Future Perspectives. Curr Stem Cell Res Ther 2013; 8(1): 25-38.
9. La Rocca G, Di Stefano A, Eleuteri E, et al. Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure. Basic Res Cardiol 2009; 104: 307-20.
10. Anzalone R, La Rocca G, Di Stefano A, et al. Role of endothelial cell stress in the pathogenesis of chronic heart failure. Front Biosci 2009; 14: 2238-47.
11. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest 2013; 123: 62-70.
12. Anzalone R, Corrao S, Lo Iacono M, et al. Isolation and characterization of CD276+/HLA-E+ human sub-endocardial mesenchymal stem cells from chronic heart failure patients: analysis of differentiative potential and immunomodulatory markers expression. Stem Cell Dev 2013; 22(1): 1-17.
13. Corrao S, La Rocca G, Lo Iacono M, et al. New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells. Curr Stem Cell Res Ther 2013; 8(1): 40-45.
14. López Y, Lutjemeier B, Seshareddy K, et al. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: A Preliminary Report. Curr Stem Cell Res Ther 2013; 8(1): 46-59.
15. Balci D, Can A. The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking. Curr Stem Cell Res Ther 2013; 8(1): 60-72.
16. Huang YC, Parolini O, La Rocca G, Deng L. Umbilical cord versus bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 2012, 21: 2900-3.
17. Rosner M, Schipany K, Shanmugasundaram B, Lubec G, Hengstschläger M. Amniotic fluid stem cells: future perspectives. Stem Cells Int 2012; 2012: 741810.
18. Preitschopf A, Zwickl H, Li K, Lubec G, Joo G, Rosner M, Hengstschläger M, Mikula M. Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy. Stem Cell Rev 2012; 8: 1267-74.
19. Moschidou D, Drews K, Eddaoudi A, Adjaye J, De Coppi P, Guillot PV. Molecular signature of human amniotic fluid stem cells during fetal development. Curr Stem Cell Res Ther 2013; 8(1): 73-81.
20. Grabowska I, Streminska W, Janczyk-Ilach K, et al. Myogenic potential of mesenchymal stem cells-the case of adhesive fraction of human umbilical cord blood cells. Curr Stem Cell Res Ther 2013; 8(1): 82-90.
21. La Rocca G, Anzalone R, Farina F. The expression of CD68 in human umbilical cord mesenchymal stem cells: new evidences of presence in non-myeloid cell types. Scand J Immunol 2009, 70: 161-2.
22. Najar M, Raicevic G, Jebbawi F, et al. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. Immunol Lett 2012; 146: 50-6.
23. Tee JY, Vaghjiani V, Liu YH, Murthi P, Chan J, Manuelpillai U. Immunogenicity and immunomodulatory properties of hepatocytelike cells derived from human amniotic epithelial cells. Curr Stem Cell Res Ther 2013; 8(1): 91-99.
24. Pratama G, Vaghjiani V, Tee JY, et al. Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One 2011, 6:e26136.
25. La Rocca G, Lo Iacono M, Corsello T, Corrao S, Farina F, Anzalone R. Human Wharton's Jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy. Curr Stem Cell Res Ther 2013; 8(1): 100-13.
26. Lo Iacono M, Anzalone R, Corrao S, et al. Perinatal and Wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies. Open Tissue Eng Regen Med J 2011; 4 (1): 72-81.